Intellia Therapeutics (NTLA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist

22.950
+0.800+3.61%

Close Jul 3 13:00 ET

22.980
+0.030+0.13%

Post 16:49 ET

2.21BMarket Cap-4273P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cathie Wood's Ark Invest Dumps Another $3.25M Worth Of Tesla Shares Amid Searing Q2 Deliveries Rally
On Wednesday, Cathie Wood-led Ark Invest made a notable move by offloading a significant number of shares in Tesla Inc (NASDAQ:TSLA), despite the recent rally driven by the company's impressive second
Benzinga21:52 ET
Intellia Therapeutics(NTLA.US) Officer Sells US$9,286.65 in Common Stock
$Intellia Therapeutics(NTLA.US)$ Officer Clark Eliana sold 405 shares of common stock on Jul 1, 2024 at an average price of $22.93 for a total value of $9,286.65.Source: Announcement What is statement
Moomoo News13:58 ET
Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
On Tuesday, Cathie Wood-led Ark Invest made significant adjustments to its portfolio, offloading a substantial number of shares in Tesla Inc (NASDAQ:TSLA) and scooping up a hefty stake in Palantir Tec
BenzingaJul 2 22:26 ET
Canaccord Genuity Maintains Buy on Intellia Therapeutics, Maintains $73 Price Target
Canaccord Genuity analyst Whitney Ijem maintains Intellia Therapeutics (NASDAQ:NTLA) with a Buy and maintains $73 price target.
BenzingaJun 27 09:38 ET
A Quick Look at Today's Ratings for Intellia Therapeutics(NTLA.US), With a Forecast Between $24 to $73
On Jun 27, major Wall Street analysts update their ratings for $Intellia Therapeutics(NTLA.US)$, with price targets ranging from $24 to $73.BMO Capital analyst Kostas Biliouris maintains with a buy ra
Moomoo NewsJun 27 09:00 ET · Ratings
Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump
On Wednesday, Cathie Wood-led Ark Invest made significant trades in Roku Inc (NASDAQ:ROKU) and Coinbase Global Inc (NASDAQ:COIN), amidst a volatile market.
BenzingaJun 26 23:33 ET

Comments

frankinglily

May 14 03:38

How does the biotech ecosystem support advancements in personalized medicine & genomics?
• Editing Genes | $CRISPR Therapeutics(CRSP.US)$ , $Intellia Therapeutics(NTLA.US)$ , $Beam Therapeutics(BEAM.US)$ , $Verve Therapeutics(VERV.US)$ , $Editas Medicine(EDIT.US)$
• Creating Therapies | $Prime Medicine(PRME.US)$ , $Sana Biotechnology(SANA.US)$
• Building DNA | $Twist Bioscience(TWST.US)$ , $Ginkgo Bioworks(DNA.US)$ , $Pacific Biosciences of California(PACB.US)$ , $Illumina(ILMN.US)$
• Dis...

areecep

Feb 22 21:18

Cathie Wood vs Warren Buffett

If you had invested $10,000 in Cathie Wood's $ARK Innovation ETF(ARKK.US)$ and Warren Buffett's Berkshire Hathaway $Berkshire Hathaway-B(BRK.B.US)$ at different time frames here's how much you'd have today.
When $ARKK launched in 2014
Total Returns:
$BRK.B $28.6K
$ARKK $27.4K
5 years ago
Total Returns:
$BRK.B $19.7K
$ARKK $11.7K
3 years ago
Total Returns:
$BRK.B $16.4K
$ARKK $3.3K
1 year ago
Total Returns:
$BRK.B $12.8K
$ARKK $12.4K
At the start of 2024
Total Returns:
$BR...

areecep: Warren Buffett vs Cathie Wood over the last 3 years

JESSE JAMES8832

Feb 15 16:07

this might be my next swing

$Intellia Therapeutics(NTLA.US)$

Moomoo AI

Feb 7 05:17

Insiders selling shares at low prices may signal expected stock weakness. The absence of insider buying and increased selling over the past year suggest the shares aren't cheap, making the company a cautious investment.